Rifabutin for the Treatment of <i>Helicobacter Pylori</i> Infection: A Review
Nowadays, apart from having to know first-line <i>Helicobacter pylori</i> eradication regimens well, we must also be prepared to face treatment failures. The aim of this review is to summarize the role of rifabutin in the management of <i>H. pylori</i> infection. Bibliographi...
Main Author: | Javier P. Gisbert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/1/15 |
Similar Items
-
Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of <i>Helicobacter pylori</i>: Randomized ERADICATE Hp Trial
by: Ira N. Kalfus, et al.
Published: (2020-10-01) -
Rifabutin-Based Rescue Therapy for <i>Helicobacter pylori</i> Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients
by: Davide Giuseppe Ribaldone, et al.
Published: (2019-02-01) -
Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for Helicobacter pylori Eradication Failure
by: Jihee Sung, et al.
Published: (2017-02-01) -
Rescue Therapy with Furazolidone in Patients with at Least Five Eradication Treatment Failures and Multi-Resistant <i>H. pylori</i> infection
by: Elena Resina, et al.
Published: (2021-08-01) -
Optimization Strategies Aimed to Increase the Efficacy of <i>Helicobacter pylori</i> Eradication Therapies with Quinolones
by: Javier P. Gisbert
Published: (2020-11-01)